Results for:(51 found)
May 3, 2013 9:08AM on Top StocksBy Jim Cramer

Unlike biotechs, many of these companies are pouring money into share buybacks -- instead of their long-term pipelines.

May 2, 2013 3:56PM on Top StocksBy StreetAuthority

Great strides are being made at these off-the-radar drug development companies. Here are 3 emerging players to watch.

Apr 25, 2013 9:37AM on Top StocksBy Jim Cramer

The only explanation for recent stock action is market players following others blindly. The bulls just have to hope analysts don't think this is National Lemming Week.

Apr 24, 2013 10:29AM on Top StocksBy TheStreet Staff

With the sector stocks at all-time highs, analysts fear that investors will sell at first sign of trouble.

Apr 18, 2013 9:44AM on Top StocksBy StreetAuthority

Shares of this medical devices company are trading at a record-low valuation.

Apr 17, 2013 9:03AM on Top StocksBy Jim Cramer

The sector's revaluation is on, and these names in particular have made some stunning moves.

Apr 15, 2013 9:08AM on Top StocksBy Jim Cramer

Keep that in mind as the market reacts to China.

Apr 11, 2013 9:23AM on Top StocksBy Benzinga

Amgen, Celgene and Pharmacyclics see short interest drop recently.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

TOP STOCKS

Scary story: the 2013 market looks like 1987

All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More